Pay in 4 interest-free payments of $5.91 Learn more
Ships within 48 hours · Estimated delivery Sep 9 - Sep 14
Patients with high-sensitivity variants benefit from slower tapers, while those with lower sensitivity may discontinue more rapidly
However, patients with type 2 diabetes require alternative glycemic management strategies before discontinuation, and gradual transition to lifestyle-focused maintenance may optimize outcomes for all patients
Mounjaro (tirzepatide): A dual GIP/GLP-1 receptor agonist that activates two hormone pathways
10,335,462covers a subcutaneous formulation, 0.1-10 mg/mL semaglutide, pH 6.5-8.5, weekly 0.5-1.0 mg doses for T2DM
In clinical trials, significant weight loss was observed over months, not days
US$ 24.15
US$ 24.56
US$ 27.66
US$ 24.73
US$ 27.33
US$ 26.57
US$ 25.48
